An implant includes a pressure sensor, a controller for acquiring pressure data from the sensor, and an acoustic transducer for converting energy between electrical energy and acoustic energy. A capacitor is coupled to the acoustic transducer for storing electrical energy converted by the transducer and/or for providing electrical energy to operate the implant. The acoustic transducer may operate alternatively or simultaneously as an energy exchanger or an acoustic transmitter. During use, the implant is implanted within a patient's body, and an external transducer transmits a first acoustic signal into the patient's body, to energize the capacitor. The implant then obtains pressure data, and transmits a second acoustic signal to the external transducer, the second acoustic signal including the pressure data.
|
19. A surgical An implant, comprising:
a controller configured for controlling the operation of the implant; and for generating an electrical communication signal;
one or more acoustic transducers;
circuitry for collectively configuring the one or more acoustic transducers to convert the electrical communication signal into an acoustical acoustic communication signal for transmission transmitted to a location external to the implant, and to convert acoustic energy received from a location external to the implant into electrical energy used to support operation of the implant; and
an energy storage device configured for storing the electrical energy converted from acoustic energy, wherein the energy storage device comprises a first, relatively fast-charging capacitor and a second, relatively slow-charging capacitor, the first and second capacitors being coupled to the one or more acoustic transducers such that the first capacitor is charged first and the second capacitor is charged only upon substantially substantial charging of the first capacitor.
0. 37. An implant, comprising:
a sensor;
a controller that generates an electrical communication signal containing data measured by the sensor;
one or more acoustic transducers;
circuitry for collectively configuring the one or more acoustic transducers to convert acoustic energy received from a location external to the implant into electrical energy used to support operation of the implant, and to convert the electrical communication signal generated by the controller into an acoustic communication signal transmitted to a location external to the implant; and
an energy storage device configured for storing the electrical energy converted from acoustic energy by the one or more transducers, wherein the energy storage device comprises a first, relatively fast-charging capacitor and a second, relatively slow-charging capacitor, the first and second capacitors coupled to the one or more acoustic transducers such that the first capacitor is charged first and the second capacitor is charged only upon substantial charging of the first capacitor.
1. A surgical An implant, comprising:
a sensor for measuring intra-body diagnostic data;
a controller configured for generating that generates an electrical communication signal containing the measured diagnostic data;
one or more acoustic transducers;
circuitry for collectively configuring the one or more acoustic transducers to convert acoustic energy received from a location external to the implant into electrical energy used to support operation of the implant, and to convert the electrical communication signal received generated by the controller into an acoustical acoustic communication signal for transmission transmitted to a location external to the implant; and
an energy storage device configured for storing the electrical energy converted from acoustic energy by the one or more transducers, wherein the energy storage device comprises a first relatively fast-charging capacitor and a second relatively slow-charging capacitor, the first and second capacitors being coupled to the one or more acoustic transducers such that the first capacitor is charged first and the second capacitor is charged only upon substantially substantial charging of the first capacitor.
2. The implant of
3. The implant of
4. The implant of
5. The implant of
6. The implant of
7. The implant of
8. The implant of
9. The implant of
10. The implant of
11. The implant of
12. The implant of
13. The implant of
15. The implant of
16. The implant of
17. The implant of
18. The implant of
0. 20. The implant of
0. 21. The implant of
0. 22. The implant of
0. 23. The implant of
0. 24. The implant of
0. 25. The implant of
0. 26. The implant of
0. 27. The implant of
28. The implant of
0. 29. The implant of
30. The implant of
0. 31. The implant of
0. 32. The implant of
0. 33. The implant of
0. 34. The implant of
0. 35. The implant of
0. 36. The implant of
0. 38. The implant of claim 19, wherein the one or more acoustic transducers are configured by the circuitry in a full-duplex mode, such that the one or more acoustic transducers can simultaneously convert the acoustic energy into electrical energy and convert the electrical communication signal into the acoustic communication signal.
0. 39. The implant of claim 38, wherein the one or more transducers comprise at least one receive transducer for converting acoustic energy into electrical energy, and at least one transmit transducer for converting the electrical communication signal into the acoustic communication signal.
0. 40. The implant of claim 38, wherein the one or more transducers comprises at least one transducer configured by the circuitry for converting acoustic energy into electrical energy, and at least one transducer for converting the electrical communication signal into the acoustic communication signal.
0. 41. The implant of claim 19, wherein the one or more acoustic transducers are configured by the circuitry in a half-duplex mode, such that the one or more acoustic transducers can alternatively convert the acoustic energy into the electrical energy, and convert the electrical communication signal into the acoustic communication signal.
0. 42. The implant of claim 19, wherein the one or more transducers are collectively configured by the circuitry for converting an acoustic communication signal transmitted from a location external to the implant to another electrical communication signal, the controller configured for detecting the other electrical communication signal.
0. 43. The implant of claim 42, wherein the controller is configured for extracting one or more commands from the other electrical communication signal and controlling the implant in response to the one or more commands.
0. 44. The implant of claim 42, wherein the controller is configured for activating or deactivating the energy storage device in response to the one or more commands.
0. 45. The implant of claim 42, wherein the controller is configured for monitoring when the one or more acoustic transducers are converting acoustic energy into electrical energy, and for activating the implant when the transducers stop converting acoustic energy into electrical energy.
0. 46. The implant of claim 28, each transducer further comprising a first electrode attached to an external surface of the piezoelectric layer and a second electrode attached to an internal surface of the piezoelectric layer.
0. 47. The implant of claim 28, wherein the piezoelectric layer comprise poly vinylidene fluoride.
0. 48. The implant of claim 19, wherein the energy storage device is rechargeable.
0. 49. The implant of claim 19, further comprising a sensor for acquiring diagnostic data, wherein the electrical communication signal generated by the controller comprises the diagnostic data.
0. 50. The implant of claim 19, wherein the electrical energy is alternating current electrical energy, and wherein the circuitry is configured for converting alternating current electrical energy into direct current electrical energy for storage in the energy storage device.
0. 51. The implant of claim 19, wherein the controller is configured to reset the implant when the energy storage device is being charged.
0. 52. The implant of claim 19, wherein the controller is configured for automatically switching the implant off when the electrical energy available from the energy storage device falls below a predetermined threshold.
|
This application is a Continuation-in-Part of application Ser. No. 09/690,615, filed Oct. 16, 2000 now U.S. Pat. No. 6,628,989, the disclosure of which is expressly incorporated herein by reference.
The present invention relates generally to devices for implantation within a patient's body, particularly to pressure sensors that may be implanted within a body, and more particularly to implantable pressure sensors that may be energized, activated, controlled, and/or otherwise communicate via acoustic energy.
Devices are known that may be implanted within a patient's body to monitor one or more physiological conditions and/or to provide therapeutic functions. For example, sensors or transducers may be located deep within the body for monitoring a variety of properties, such as temperature, pressure, strain, fluid flow, chemical properties, electrical properties, magnetic properties, and the like. In addition, devices may be implanted that perform one or more therapeutic functions, such as drug delivery, defibrillation, electrical stimulation, and the like.
Often it is desirable to control such devices once they are implanted within a patient by external command, for example, to obtain data, and/or to activate or otherwise control the implant. An implant may include wire leads from the implant to an exterior surface of the patient, thereby allowing an external controller or other device to be directly coupled to the implant. Alternatively, the implant may be remotely controlled, e.g., using an external induction device. For example, an external radio frequency (RF) transmitter may be used to communicate with the implant. RF energy, however, may only penetrate a few millimeters into a body, because of the body's dielectric nature. Thus, RF energy may not be able to communicate effectively with an implant that is located deep within the body. In addition, although an RF transmitter may be able to induce a current within an implant, the implant's receiving antenna, generally a low impedance coil, may generate a voltage that is too low to provide a reliable switching mechanism.
In a further alternative, electromagnetic energy may be used to control an implant, since a body generally does not attenuate magnetic fields. The presence of external magnetic fields encountered by the patient during normal activity, however, may expose the patient to the risk of false positives, i.e., accidental activation or deactivation of the implant. Furthermore, external electromagnetic systems may be cumbersome and may not be able to effectively transfer coded information to an implant.
Accordingly, a sensor, such as a pressure sensor, that may implanted within a patient's body, and may be energized by, controlled by, and/or otherwise communicate effectively with an external interface would be considered useful.
The present invention is generally directed to implants that may be implanted, e.g., using open surgical or minimally invasive techniques, or otherwise located within a mammalian body for monitoring pressure or other physiological parameters and/or for performing one or more therapeutic functions.
In accordance with a first aspect of the present invention, an implant is provided that includes a pressure sensor for measuring intra-body pressure. A controller is coupled to the pressure sensor for acquiring pressure data from the pressure sensor. One or more acoustic transducers are provided for converting energy between electrical energy and acoustic energy. Preferably, the one or more acoustic transducers are configured for converting acoustic energy from a source external to the implant into electrical energy and/or for transmitting an acoustic signal including the pressure data to a location external to the implant. One or more energy storage devices are coupled to at least one of the one or more acoustic transducers, the energy storage device(s) configured for storing electrical energy converted by the one or more acoustic transducers. The energy storage device(s) may be coupled to the controller for providing electrical energy to support operation of the implant. The energy storage device may include one or more capacitors, for example, a first relatively fast-charging capacitor and a second relatively slow-charging capacitor. In addition or alternatively, the energy storage device may include a rechargeable and/or nonrechargeable battery.
In a preferred embodiment, the one or more acoustic transducers may be a single transducer configured to operate alternatively as either an energy exchanger or an acoustic transmitter. Alternatively, the acoustic transducers may include an acoustic transmitter coupled to the controller for transmitting the acoustic signal to a location external to the body. In addition or alternatively, the acoustic transducers may include an energy exchanger coupled to the energy storage device, the energy exchanger including a piezoelectric layer for converting acoustic energy striking the piezoelectric layer into electrical energy.
The components of the implant may be attached to a substrate, such as a printed circuit board (PCB), and may be secured within a casing. The casing may include one or more openings through which active areas of the pressure sensor and/or the energy transducer may be exposed to a region exterior to the casing. Alternatively, the active area of the pressure sensor may be covered with a seal, such as silicone, Parylene C, or a relatively thin metal layer. In a further alternative, the casing may include a relatively thin foil or thin-walled region for sealing at least one of the pressure sensor and the energy transducer from a region exterior to the casing. The casing may be filled with a fluid, gel, and/or low modulus material, such as silicone, for coupling the pressure sensor and/or the energy transducer to the foil or thin-walled region. Thus, the thin-walled region may be used to couple the pressure sensor and/or energy transducer to a region exterior to the casing.
In accordance with another aspect of the present invention, a method is provided for making an energy exchanger for converting between acoustic and electrical energy. First, a layer of piezoelectric polymer is provided, such as a fluorocarbon polymer, preferably poly vinylidene fluoride (PVDF), or a copolymer of PVDF, such as PVDF-TrFE. The layer of polymer may be etched, e.g., to cleave carbon-fluorine, carbon-hydrogen, and/or carbon-carbon bonds, for example, using a sodium naphthalene solution (for carbon-fluorine bonds), or using a gas phase plasma treatment including oxygen, air, Argon, Helium, and/or other gas plasma (e.g., SF6). A conductive layer may be applied onto the layer of polymer. The layer of polymer generally includes first and second surfaces, and first and second conductive layers are applied onto the first and second surfaces of the layer of polymer.
An adhesive, such as an epoxy or acrylic adhesive, is applied, e.g., atomized, over a substrate including one or more cavities therein. The piezoelectric layer is applied to a surface of the substrate. Pressure may be applied between the piezoelectric layer and the substrate, thereby causing the piezoelectric layer to become at least partially depressed within the one or more cavities. The adhesive may be cured, for example, using heat and/or pressure, and/or by exposure to visible or ultraviolet light.
The energy exchanger may then be incorporated into an implant, such as that described above. A substrate, e.g., a printed circuit board (PCB), e.g., made from FR4, Rogers, ceramic, Kapton, Teflon, PVDF, and/or PEEK, may be provided having an opening therethrough. A pressure sensor may be attached to the substrate adjacent the opening, the pressure sensor including an active area exposed via the opening for measuring intra-body pressure. A controller may be attached to the substrate and coupled to the pressure sensor for acquiring pressure data from the pressure sensor. An energy exchanger may be attached to the substrate, the energy exchanger coupled to the controller for at least one of converting acoustic energy from a source external to the implant into electrical energy and transmitting an acoustic signal, e.g., including the pressure data and optionally other information, to a location external to the implant. Finally, an energy storage device may be attached to the substrate and coupled to the energy exchanger, the energy storage device configured for storing electrical energy converted by the acoustic transducer and/or for providing electrical energy to support operation of the implant. The substrate and attached components may then be received in a casing for sealing the implant.
In accordance with yet another aspect of the present invention, a method is provided for acquiring data from an implant, such as that described above, that is implanted within a patient's body, using an external transducer located outside the patient's body. Generally, the external transducer transmits a first acoustic signal into the patient's body, the first acoustic signal being converted into electrical energy for operating the implant. The first acoustic signal may include an identification code (e.g., a serial number, model number, and/or other identifier) identifying a target implant, or other information, which may be interpreted by the implant. The implant may confirm that the identification code matches the implant, whereupon the implant may sample data and transmit a second acoustic signal to the external transducer.
In response, the external transducer receives the second acoustic signal from the implant, the acoustic signal including data related to a condition with the patient's body measured by the implant. Preferably, the external transducer automatically switches from an energizing mode after transmitting the first acoustic signal to a receiving mode for receiving the second acoustic signal. Upon completion of transmitting the data, e.g., after a power level of the implant falls below a predetermined level and/or after a predetermined time, the implant returns to a passive mode, awaiting further energizing or activation by the external transducer. Alternatively, after receiving the second acoustic signal, the external transducer may automatically switch back and forth from the energizing mode to the receiving mode, thereby alternately energizing the implant and receiving data from the implant. For example, the external transducer may transmit an energizing signal during any pause in operation of the implant, e.g., whenever the energy exchanger is available to receive the energizing signal. This may allow the external transducer to maintain the implant substantially fully charged, thereby allowing substantially indefinite operation. In a further alternative, the first and second acoustic signals may be transmitted simultaneously, e.g., at different frequencies.
In an alternative embodiment, the first acoustic signal transmitted by the external transducer may be a diagnostic signal, e.g., including a broad band signal or a scanning signal, that may be used to determine an optimal frequency for communicating with the implant. The implant may transmit at different frequencies in response to the diagnostic signal, and the external transducer may determine the optimal frequency for communicating with the implant. Alternatively, when the implant detects the diagnostic signal at an optimal frequency, it may respond with a second acoustic signal identifying or merely transmitting at the optimal frequency.
In yet another alternative embodiment, the energy storage device of the implant may include a relatively fast-charging device and a relatively slow-charging device. When the implant receives a first acoustic signal, it may immediately charge the fast-charging device, thereby allowing the implant to transmit a prompt response to the external transducer, e.g., within about fifty to two hundred milliseconds or less. The transmitted response may include an identification code, a confirmation that the implant is operational, and the like. While the implant is responding, the slow-charging device may continue to charge, e.g., to support subsequent operation of the implant during data sampling and transmission.
Other objects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
The invention is herein described, by way of example only, with reference to the accompanying drawings, wherein:
Turning to the drawings,
The sensor 12 is preferably a pressure sensor for measuring intra-body pressure. The sensor 12 may measure pressure within a range as low as a few millibars gauge (e.g., pressure ranges experienced within the cranium or within the pulmonary artery) and up to about 400 millibars gauge (e.g., blood pressure ranges experienced during systole). In addition, because the barometric pressure may vary by location, i.e., altitude, the absolute pressure range capacity of the sensor is preferably between about 650 and 1450 millibars absolute.
In a preferred embodiment, the sensor 12 is an absolute variable capacitance type pressure sensor. Alternatively, a piezoresistive pressure sensor may be used, although the energy consumption of this type of sensor may be substantially higher than a variable capacitance pressure sensor. For example, a typical piezoresistive sensor may have a bridge resistance of about five kiloohms (5 kΩ). Assuming that one volt (1 V) is sufficient to allow pressure sampling, a current of at least about 0.2 milliAmperes (mA) would be required to operate the sensor. This may be about one hundred times more than the current required to obtain pressure samples using a variable capacitance pressure sensor.
Some reduction in power consumption of piezoresistive pressure sensors may be obtained by reducing the sampling rate of the sensor or otherwise reducing the duty cycle of the implant. Alternatively, to reduce power consumption, a sample-and-hold circuit (not shown) may be provided for capturing voltages, and an analog-to-digital converter (also not shown) may be provided for converting the voltages when desired. Thus, the current may be on for relatively short times during each sampling cycle.
Preferably, a silicon MEMS-based pressure sensor is used, because of its relative small size, e.g., smaller than about four millimeters (4 mm) maximum footprint, e.g., not more than about four millimeters (4 mm) width by four millimeters (4 mm) length. Preferably, the sensor is no larger than about 0.8 mm width by about 2.1 mm length by about 0.3 mm thickness. Silicon is a particularly useful material for the sensor 12, as it generally does not suffer from creep and fatigue, and therefore may result in a substantially stable sensor. MEMS-based sensors are presently preferred because they may be manufactured in large volume at relatively low cost compared to other sensors. Other materials that may be used include titanium, as is used for the Chronicle™ device manufactured by Medtronic, Inc. Preferably, the sensor 12 is made from biocompatible materials, although the sensor 12 may be coated, if necessary or desired, with a biocompatible and/or chemically resistive coating (not shown), as will be appreciated by those skilled in the art.
In alternative embodiments, one or more other sensors may be provided instead of or in addition to a pressure sensor. For example, the sensor 12 may include one or more biosensors capable of measuring physiological parameters, such as temperature, electrical impedance, position, strain, pH, fluid flow, and the like. U.S. Pat. Nos. 4,793,825 issued to Benjamin et al. and 5,833,603 issued to Kovacs et al. disclose exemplary embodiments of biosensors that may be provided. The disclosure of these references and others cited therein are expressly incorporated herein by reference. The sensor 12 may generate a signal proportional to a physiological parameter that may be processed and/or relayed by the controller 18 to the energy transducer 14, as described further below. Alternatively, the sensor 12 may be configured to monitor a radiation dose including ionizing, magnetic and/or acoustic radiation, to monitor flow in a bypass graft, to produce cell oxygenation and membrane electroporation, and the like.
In further alternatives, a device for providing one or more therapeutic functions (not shown) may be provided in addition to or instead of the sensor 12. For example, the device may be used to activate and/or control a therapeutic device implanted within a patient's body, such as an atrial defibrillator, a pain relief stimulator, a neuro-stimulator, a drug delivery device, and/or a light source used for photodynamic therapy.
Turning to
The energy transducer 14 generally includes a substrate 20 including one or more cavities 22 therein, such as the array of cavities 22 shown in
A substantially flexible piezoelectric layer 24 is attached to the substrate 20 across the cavities 22. The piezoelectric layer 24 generally includes a polymer layer 28, preferably a fluorocarbon polymer, such as poly vinylidene fluoride (PVDF). The polymer layer 28 may have a thickness of between about three and two hundred fifty micrometers (3-250 μm), and preferably about thirty micrometers (30 μm) or less. A first conductive layer 30 is provided on an external surface of the polymer membrane 28 and a second conductive layer 32 provided on an internal surface of the polymer membrane 28. The second conductive layer 32 may be coupled to a conductive region 36 provided on a wall of the cavities 22. A pad 34 is provided on a lower surface of the substrate 20 for coupling the second conductive layer 32 to a printed circuit board (not shown), as described further below.
To manufacture the energy transducer 14, a substantially flexible polymer layer 28, such as a PVDF membrane, is provided. Because PVDF is generally chemically inert, the polymer layer 28 may need to be activated, e.g., using an etching process. For example, a sodium napthalene solution may be used to chemically attack the PVDF to cleave the carbon-fluorine bonds and/or other solutions to cleave the carbon-hydrogen bonds and/or carbon-carbon bonds in the material. Alternatively, a gas phase plasma treatment, e.g., using an oxygen, air, Helium, and/or Argon plasma, may be used.
A substantially planar substrate 20 is provided, and one or more cavities 22 are formed in a surface of the substrate 20, for example, by mechanical drilling, laser drilling, or punching. Alternatively, the cavities 22 may be etched into the substrate 20, e.g., using VLSI/micro-machining technology or any other suitable technology.
A thin layer of adhesive (not shown) may be applied over the substrate 20, such as an epoxy or acrylic-based adhesive. Preferably, a relatively low viscosity (e.g., less than one thousand centi-poise) adhesive is used that may be atomized over the substrate 20. More preferably, the adhesive is light-activated, thereby facilitating positioning of the piezoelectric layer 24 over the substrate 20 before the adhesive is cured. The piezoelectric layer 24 is applied against the adhesive over the substrate 20. Alternatively, individual piezoelectric layers (not shown) may be bonded or otherwise attached over one or more individual cavities 22. The cavities 22 may be filled with a gas, such as air, to a predetermined pressure, e.g., ambient pressure or a predetermined vacuum, that may be selected to provide a desired sensitivity and ruggedness for the energy transducer 14.
The assembled substrate 20 and piezoelectric layer 24 may be placed in a pressure chamber, and a predetermined pressure applied against the piezoelectric layer 24. This may cause the piezoelectric layer 24 to press against the substrate 20, e.g., to facilitate spreading the adhesive more evenly between the substrate 20 and the piezoelectric layer 24. In addition, the predetermined pressure preferably causes the piezoelectric layer 24 to at least partially enter the cavities 22, thereby creating depressions in the piezoelectric layer 24 corresponding to the cavities 22, as best seen in
Thus, the piezoelectric layer 24 may include depressions, which may be useful for enhancing the efficiency and/or sensitivity of the energy transducer 12. For example, the depressions may enhance the conversion of an acoustic pressure wave striking the piezoelectric layer 24 into mechanical strain, resulting in an increased yield of electrical energy for a given pressure amplitude. The depressions may also be used to customize the natural resonant frequency of the piezoelectric layer 24. The depth of the depressions may be between about one and two hundred micrometers (1-200 μm), and preferably between about twenty and one hundred micrometers (20-100 μm), although depths greater than this may also increase efficiency as compared to a planar piezoelectric layer 24 without depressions. To ensure that these depths are consistently reproducible, the depth of the depressions may be measured, for example, using a non-contact optical profiler.
Both surfaces of the polymer layer 28 may be coated with conductive layers 30, 32, preferably metallization layers, at any stage of manufacturing. For example, the conductive layers 30, 32 may be applied either before or after the piezoelectric layer 24 has been bonded to the substrate 20. Because the current encountered during use of the energy transducer 14 is relatively low (e.g., about thirty microamperes (30 μA) or less, and preferably about five microamperes (5 μA) or less), a thickness of the conductive layers 30, 32 may be relatively thin, e.g., fifteen micrometers (15 μm) or less, and more preferably about two hundred nanometers (200 nm) or less. The thickness of the conductive layers 30, 32 may be substantially equal to or different from one another. For example, the first or outer conductive layer 30 may be substantially thicker than the second or inner conductive layer 32 to protect the energy transducer 14 from environments to which it is exposed, such as those encountered within a human body. The conductive layers 30, 32 may be formed from biocompatible and/or metallic materials, including one or more of gold, platinum, titanium, tantalum, palladium, vanadium, copper, nickel, silver, and the like.
The conductive layers 30, 32 may be coated on the surfaces of the polymer layer 28 using any known method, such as depositing an electro-less nickel, gold, or copper base layer, followed by depositing a galvanic coating, including any of the materials listed above. The conductive layers 30, 32 may be deposited using physical vapor deposition, chemical vapor deposition, sputtering, and/or other gas phase coating processes known to those skilled in the art. The conductive layers 30, 32 may be applied as single layers or as multiple layers of one or more materials in order to optimize the layers' electrical, mechanical, and/or chemical properties. Exemplary methods for making the piezoelectric layer 24 may be found in “Handbook of Physical Vapor Deposition (PVD) Processing,” Donald M. Mattox (ISBN 0-8155-1422-0 Noyes publications, 1998) and “Handbook of Deposition Technologies for Films and Coatings,” Rointan F. Bunshah (ed.), (Noyes Publications; ISBN: 0815513372 2nd edition 1994.) The disclosures of these references, as well as any others cited therein, are incorporated herein by reference.
The method described above may be used to make individual energy transducers or alternatively to make a plurality of energy transducers. For example, a plurality of energy transducers may be made as a single panel, and, after the metallization process, the panel may be separated into individual energy transducers. The separation may be accomplished using known dicing systems and methods, for example, using a dicing machine known to those in the microelectronics industry for dicing silicon wafers, a knife cutter, a milling machine, or a laser, e.g., a diode laser, a neodymium YAG laser, a CO2 laser, or an excimer laser. Upon separation of the individual energy transducers, the electrical impedance of each of the energy transducers may be measured to confirm their integrity and proper operation. Additional information on acoustic transducers or energy exchangers appropriate for use with implants in accordance with the present invention may be found in U.S. Pat. No. 6,140,740, the disclosure of which is expressly incorporated herein by reference.
In an alternative embodiment, the substrate 20 may be formed from silicon, with or without electronics. The cavities 22 may be formed therein, the piezoelectric layer 24 may be attached to the substrate 20, and the surfaces metalized, generally as described above. In order to avoid large capacitances, an insulating oxide or other ring (not shown) may be provided around the cavities 22. The bottom of the cavities 22 may be sealed using an adhesive, e.g., an underfill adhesive used during the flip-chip process.
Returning to
Turning to
The rectifier 40 is coupled to the energy transducer 14 for converting electrical energy generated by the energy transducer 14 into a form suitable for powering components of the implant 10. For example, the rectifier 40 may be configured for converting incoming alternating current (AC) voltage from the energy transducer 14 into direct current (DC) voltage for storage by the energy storage device 16 and/or for powering the controller 18 and other components of the implant 10. The rectification may be performed by diodes arranged in a configuration suitable for the requirements of the mode of operation, preferably resulting in a passive circuit that draws substantially no current.
Alternatively, other rectification circuits (not shown) may be used, including Schottky diodes, voltage triplers or other multiplier circuits, and the like. In addition, the rectifier 40 may include an overvoltage protector (not shown), which may prevent the energy storage device 16 from overcharging, e.g., to unsafe levels. For example, the overvoltage protector may include a Zener diode, or a transistor that opens at a predetermined threshold voltage.
Returning to
The reset circuitry 42 preferably monitors the voltage of the energy storage device 18 in a substantially passive manner. For example, the reset circuitry 42 may include a field-effect transistor (FET) that is switched on when its gate voltage exceeds a predetermined threshold. Thus, the reset circuitry 42 may be passive, i.e., drawing substantially no current from the energy storage device 16.
The signal detect circuitry 44 generally is coupled to the energy transducer 16 for monitoring when the energy transducer 16 is receiving acoustic signals from a source external to the implant 10. Preferably, the signal detect circuitry 44 is a passive FET circuit, thereby drawing substantially no current. The signal detect circuitry 44 may also include a smoothing capacitor (not shown) and/or logic for reducing the sensitivity of the signal detect circuitry 44 to spurious transient signals. The signal detect circuitry 44 may provide a communication channel into the implant 10, e.g., to pass commands and/or information in the acoustic excitation signals received by the energy transducer 16 for use by the controller 18. In addition, the signal detect circuitry 44 may pass commands or other signals to controller 18, e.g., that acoustic excitation signals have been discontinued, and/or that the implant 10 should become operative. For example, when the implant 10 is configured for operation in half-duplex mode, the signal detect circuitry 44 may monitor for termination of an energizing transmission for charging the energy storage device 16, whereupon the controller 18 may begin sampling and/or transmitting sensor data.
The transmission circuitry 46 is coupled to the energy transducer 14, and is generally responsible for preparing signals for transmission from the implant 10 to a location exterior to the implant 10. The signals are preferably digital electrical signals, which may be generated, for example, by grounding one pin of the energy transducer 14 and alternately connecting the other pin between ground and a predetermined voltage. Alternatively, the signals may be generated by alternately grounding the first pin and connecting the second pin to the predetermined voltage, and then grounding the second pin and connecting the first pin to the predetermined voltage. In a further alternative, the signal may be processed or modulated, e.g., using spread spectrum, direct sequence mixing, CDMA, or other technologies, as will be appreciated by those skilled in the art.
In an alternative embodiment (not shown), a full-bridge transmission circuit may be used for the transmission circuit. Using this circuit, pins of the energy transducer may be coupled alternately to ground and +V. For example, a first pin may be coupled to ground and a second pin coupled to +V, and then the first pin may be coupled to +V and the second pin coupled to ground. This circuit may generate signals at about twice the amplitude of the other embodiments described above.
Returning to
The analog-to-digital (A/D) converter 50 is coupled to the sensor 12, and to the control logic circuitry 52 or directly to the transmission circuit 46. The A/D converter 50 may digitize the sensor output for further processing by the controller 18 and/or for transmission by the energy transducer 14, using one of a variety of known digitization systems. For a variable capacitance pressure sensor, a switched-capacitor sigma-delta converter may be provided. Alternatively, for piezo-resistive or strain-gauge sensors, a track and hold amplifier followed by a successive approximation converter may be provided.
The A/D converter 50 may also include a calibrated voltage reference, against which measurements may be performed. Preferably, this is a bandgap reference, based upon the properties of silicon transistors. Alternatively, other reference circuits, such as Zener or buried Zener diode references, may be used.
The power management and control logic circuitry 52 may include several subsystems, such as a power management unit, a reception decoder, a transmission encoder, a state machine, and/or a diagnostic unit (not shown), which may be discrete hardware components and/or software modules. For example, an ASIC-compatible microprocessor, such as a CoolRISC processor available from Xemics, may be used for the power management and control logic circuitry 52. The power management unit may be provided for switching current on and off and/or for biasing voltages of the various components of the controller 18, particularly for any analog subcircuits, on demand. Thus, power may be supplied only to those portions or components currently in need of power, in order to conserve resources of the implant 10. The reception decoder is coupled to the signal detect circuitry 44 for decoding signals extracted by the signal detect circuitry 44 into commands to be passed to other components of the implant 10. These commands may include initialization, identification, control of system parameters, requests for sensor data or other information, and the like.
The transmission encoder is coupled to the transmission circuitry 46 and generally latches digital information supplied by the A/D converter 50 and prepares it for serial transmission by the transmission circuitry 46. The information may include an acknowledgement symbol, an identification code (e.g., a model, a serial number, or other identifier identifying the implant 10), internal status information (such as capacitor voltage), and/or measurements obtained by the sensor 12. Data may be sent using an asynchronous serial protocol, including, for example, a start bit, one or more synchronization bits, eight bits of data, a parity bit, and/or a stop bit. The data transmission rate and bit structure are preferably constructed so as to avoid data corruption due to reflections and reverberations of the acoustic signal within a body. For example, each bit of information may be made up of sixteen oscillations of the acoustic wave in order to ensure fidelity of the transmission. In addition, there may be predetermined delays between sequential transmissions, e.g., to minimize interference and/or to allow reverberations to die out.
The state machine controls the operational mode of the control logic circuitry 52. For example, it may determined the current mode (e.g., idle, decode, sample, transmit, and the like), and may contain logic for switching from one mode to another.
The diagnostic unit may include circuits used during manufacturing and/or calibration of the implant 10. This unit may not be operational after system integration, but may be awakened periodically by external command, e.g., to conduct in-vivo system diagnostics.
Turning to
Alternatively, a single-sided PCB may be used, which may result in an implant that has a smaller thickness, but which may be longer or wider to accommodate the circuits printed thereon. A longer, thinner implant may be useful for implantation in particular locations within a patient's body, as will be appreciated by those skilled in the art. In a further alternative, a single-sided or double-sided flexible PCB may be used, e.g., having a thickness of about twenty five micrometer (25 μm). After assembly, the PCB may be folded, rolled, or otherwise arranged to minimize its volume.
To protect the sensor 12 and/or to prevent drift, the sensor 12 may be covered with a protective coating, e.g., a moisture barrier (not shown). Preferably, the sensor 12 is coated with a relatively soft material, such as silicone (e.g., NuSil MED4161). This coating may substantially minimize the stiffness or stress that may be imposed upon the sensor 12, which may otherwise affect its sensitivity and stability. Other protective and/or moisture barrier layers may then be applied over this coating, such as a relatively thin metal layer and/or Parylene C, without significantly affecting performance of the sensor 12. After the sensor 12 is assembled and coated, it may be calibrated, for example, by trimming the controller 18, e.g., by fuse blowing, and/or by soldering or otherwise bonding trim resistors 17 to the print side of the PCB 11.
The energy storage device 16, preferably a capacitor, may be attached to an edge of the PCB 11, e.g., bonded using epoxy or other adhesive. Conductive glue may be used for electrical contacts. The energy transducer 14 is attached to the print side of the PCB 111, e.g., by bonding with conductive glue. Additional mechanical fixation may be achieved, if desired, using an additional adhesive, such as an epoxy, around and/or under the energy transducer 14. Alternatively, the energy transducer 14 may be bonded using a conductive epoxy for electrical pad areas, and a structural epoxy for areas away from the pads. When the energy transducer 14 is attached to the PCB 11, the active area 15 of the energy transducer 14 is disposed away from the PCB 11 and/or otherwise exposed to transmit and/or receive acoustic energy, as described further below.
Preferably, a panel of implants are assembled, e.g., by attaching the components for multiple implants onto a single PCB. To calibrate the panel (or individual implants) following assembly, the panel may be inserted into a testing and diagnostic chamber (not shown). The chamber may be thermostatically controlled to ensure substantially constant temperature. In addition, pressure within the chamber may also be controlled within pressure ranges defined by the implants' specifications, e.g., pressure ranges to which the implants may be subjected during use. Preferably, the chamber includes a “bed of nails” or similar fixture (also not shown) that provides contact between desired electrical pads on the PCB and the conductive “nails.” The nails are coupled to external diagnostic electronics that may perform diagnostics and calibration, e.g., via trimming, as required. Thus, the diagnostic electronics may communicate and/or control the implants on the panel via the nails. The testing generally includes calibration of the pressure sensors' sensitivity and offset, e.g., based upon comparison of measurements of the implants to a calibrated pressure sensor, and/or calibration of the frequency of the internal oscillator.
Once the panel has been assembled and/or calibrated, the panel may be separated into individual implants. For example, the panel may be diced using a milling machine, a dicing machine such as that used for dicing silicon wafers, a laser, or a knife-based cutter. If desired, an intermediate moisture barrier, such as Parylene C, may be applied to any or all of the components, e.g., the pressure sensor, the controller, etc., to provide additional protection for the covered components.
After separation, each implant 10 is generally placed within a box or other casing (not shown). The casing may protect the implant 10 from penetration of moisture or other body fluids, which may cause corrosion of the electrical pads or traces and/or may cause drift. The casing may also provide mechanical protection and/or may provide connection points from which to attach the implant 10, e.g., to other devices that may also be implanted within a patient. The casing may be provided from titanium, gold, platinum, tantalum, stainless steel, or other metal. Alternatively, other biocompatible materials may be used, e.g., a polymer, such as a fluorocarbon, polyamide, PEEK, preferably covered with a metallization layer to improve the polymer's performance and/or to enhance its moisture resistance. The casing may also include a connector or other attachment fixture that may facilitate connecting the implant to other devices implanted within a patient's body, e.g., for receiving a suture that extends from a stent-graft or other implanted device.
Preferably, the casing is a five-sided box, and the implant 10 is disposed within the box such that the active areas of the sensor 12 and the energy transducer 14 are exposed through the open side. The implant 10 may be sealed within the box. For example, after assembly, a lid (not shown) may be attached to the sixth side, e.g., by welding, soldering, brazing, gluing, and the like. The lid may include openings corresponding to the active areas of the sensor 12 and/or the energy transducer 14, the perimeters of which may be sealed. Alternatively, a six sided casing may be used, having one side made of a relatively thin foil, e.g., only a few microns thick. In a further alternative, a six-sided compartment may be used, with one or more walls or one or more regions of walls being thinner than the others. The interior of the casing may be filled with a non-ionic solution, e.g., silicone oil, silicone gel, or other low modulus material, for coupling the pressure sensor and the energy transducer to the foil or thin-walled regions. U.S. Pat. No. 4,407,296 issued to Anderson, the disclosure of which is expressly incorporated herein by reference, discloses a casing that may be appropriate for use with an implant, in accordance with the present invention.
With the implant 10 within the casing, it may placed in a vacuum oven, e.g., at a temperature of about eighty degrees Celsius (80 C.) for outgassing, followed by plasma treatment for surface activation. The implant 10 may be attached to the casing using an adhesive, such as an epoxy, or silicone. The outer surface of the assembled casing and implant may be covered with a layer of Parylene C for improving corrosion resistance, a polymer to improve biocompatibility, and/or a metal deposition layer to provide a final moisture barrier. Preferably, a metal coating may be applied, which may electrically ground the casing with the energy transducer 14, and then a final coating of Parylene C or other corrosion resistance coating may be applied.
Turning to
During assembly, the sensor 112, the energy storage device(s) 116, and the controller 118 may be attached to the casing, e.g., to a bottom panel 120 (shown in phantom in
Wires 119 may be bonded to provide any required electrical connections between the components, e.g., between the sensor 112, the energy exchanger(s) 114, the energy transducer(s) 116, and/or the controller 118. For example, the components may include one or more electrical contacts 121 to which ends of respective wires 119 may be soldered or otherwise bonded using known methods. The wires 119 may be bonded before testing the controller 118, e.g., in order to test operation of the entire implant 110. Alternatively, the wires 119 may be bonded after testing the controller 118 and/or other components individually or at intermediate stages of testing. For example, testing, calibration, and/or trimming the controller 118 may be completed using a probe card (not shown) that may be coupled to leads on the controller 118, e.g., similar to the bed of nails described above. During or after testing, trim resistor(s) 117 may be attached to the bottom 120 of the casing and/or electrically coupled to the controller 118 or other component. The trim resistor(s) 117 may be electrically isolated from the other components.
The subassembly may be cleaned and/or coated, similar to the previous embodiment. For example, the entire subassembly may be coated with Parylene or other moisture barrier. The sensor may be coated, for example, with silicone (NuSil), which may still expose an active area of the sensor, e.g., a membrane of a pressure sensor, to body conditions. Ground connections may be made, e.g., for the trim resistors 117 and/or other components. The casing may then be at least partially filled with potting compound, e.g., using a mold to protect the active area of the sensor 112. Preferably, the potting compound is filled to line 122 (shown in phantom in
A lid, membrane, or other seal (not shown) may be attached to the casing to protect the implant 110 from an exterior of the casing, while still coupling the active areas of the sensor 112 and/or the energy transducer 114 to the exterior, similar to the previous embodiment. The space within the casing above the potting compound 122 may be filled with a fluid to acoustically couple and/or otherwise couple the active areas to the lid, membrane, or other seal. The lid may be attached first to the energy transducer 114 and then may be secured across an open end of the casing and/or the lid may be welded to the casing open end using a laser, electron beam plasma, magnetic welding, or any other welding method. The welding may be performed in a gas environment, preferably an inert gas (e.g., helium or argon), or while the parts are immersed within a fluid. Alternatively a thin membrane may be chemically etched or diffusion bonded to the lid.
Wire bonding may have advantages over the flip-chip process described above. For example, wire bonding may eliminate need for the PCB 11, and may allow the pressure sensor or other sensor to be mounted face up within the casing, which may simplify assembly. In addition, wire bonding may allow the implant 110 to be narrower in width and/or shorter in length than the previous embodiment. Because of the elimination of the PCB 11, the implant 110 may be easier, less expensive, and/or faster to assemble.
Turning to
First, the probe 72 may be coupled to the patient, e.g., placed against the patient's skin 92, and the energy transducer 74 operated in the energizing mode, transmitting acoustic energy from its energy transducer to the implant 10 through the patient's body 90. The acoustic energy from this energizing transmission passes through the patient's body 90, at least some of the energy striking the active area 15 of the energy transducer 14 of the implant 10. The energy transducer 14 converts the acoustic energy into electrical energy, e.g., which may be used to charge the energy storage device (not shown) or otherwise operate the implant 10, and/or to receive commands from the external transducer 70, as explained further below.
Initially, the external transducer 70 may be operated in a diagnostic mode. For example, the external transducer 70 may transmit a broadband signal or a scanning signal, i.e., scanning through a range of frequencies, and wait for the implant 10 to respond. The implant 10 may transmit at different frequencies in response to the diagnostic signal, and the external transducer 70 may determine the optimal frequency for communicating with the implant based upon the responses. For example, the external transducer 70 may repeatedly charge the implant 10 using different frequency signals and measure the length of time that the implant 10 is capable of sampling and transmitting data signals at each frequency to determine the optimal frequency. Alternatively, when the implant 10 detects the signal, it may transmit a response, the response being at an optimal frequency that should be used to communicate with the implant 10.
Once the external transducer 70 has determined the optimal frequency for communicating with the implant 10 (or the external transducer 70 may already know the proper frequency to use), the external transducer 70 may then begin its operation in energizing mode, transmitting acoustic energy from its energy transducer 74 through the patient's body 90 to the implant 10, which is stored in the energy storage device. The energy storage device may continue to store energy until a predetermined voltage is achieved, e.g., about eight Volts (8 V), and then the controller (not shown) may automatically disconnect the energy storage device from the energy transducer 14. Alternatively, the energy storage device may continue to store energy until a stop command is transmitted by the external transducer 70.
After a predetermined time, e.g., between about five and sixty seconds (5-60 sec.), the external transducer 70 may automatically cease the energizing transmission. At the end of the energizing transmission, the external transducer 70 may send an identification code, e.g., a predetermined pulse sequence, identifying a specific implant. In addition, the external transducer 70 may send a stop command, an activation command, a sampling rate instruction, or one or more other instructions. The external transducer 70 may then automatically switch to receiving mode and await data transmission from the implant 10 matching the identification code. Alternatively, the external transducer 70 may be switched manually to its receiving mode.
The controller of the implant 10 may detect the end of the energizing transmission and the identification code. The controller may confirm that the identification code matches the implant 10, and automatically activate the implant 10. Alternatively, the controller may acquire an activation command or other instructions from the external transducer 70, such as a sampling rate and the like, and activate in accordance with the instructions.
For example, once activated, the implant 10 may draw electrical energy from the energy storage device, and begin to sample data using the sensor 12. The controller may receive signals, e.g., raw pressure readings, from the sensor 12, digitize and/or otherwise process the signals, and transmit sensor data using the energy transducer 14. For example, the A/D converter may convert the raw pressure readings into digital data signals, which may be further processed by the controller in preparation for data transmission. The energy transducer 14 may convert the processed digital data signals from the controller into acoustic energy that may be transmitted through the patient's body 90 to the external transducer 70.
The implant 10 may continue to sample data and transmit the data signals until the voltage of the energy storage device 16 falls below a predetermined threshold, e.g., below a level at which the pressure sensor may not continue to operate effectively, such as 1.5 volts. For example, using a 4.7 μF tantalum capacitor for the energy storage device 16, the implant 10 may operate for between about two and six seconds (2-6 sec.). After the voltage falls below the predetermined threshold, the controller may automatically discontinue operation of the implant 10 and return to a passive state until energized and activated by the external transducer. The controller may also include additional information in the data transmission, e.g., an initial confirmation of instructions received from the external transducer, an identification code identifying the implant 10, and/or a stop notice when the signal transmission is being discontinued.
Thus, the external transducer 70 and one or more implants within the patient may operate in a cooperative manner. The external transducer 70 may energize one or more implants with an energizing transmission and/or may send instructions to individual or multiple implants. Thus, the external transducer 70 may selectively activate and receive data from one or more implants. The activated implant(s) may acquire data, transmit data signals to the external transducer 70 as acoustic energy, and then automatically return to their passive mode awaiting further instructions. The external transducer 70 may receive data from the one or more implants, which may be stored in memory 78 of the external transducer 70 or transferred to other equipment for use by medical personnel and the like.
In an alternative embodiment, the energy storage device may include a first relatively fast-charging capacitor and a second relatively slow-charging capacitor (not shown). For example, the first capacitor, which may be a relatively low-value capacitor, may be coupled to the energy transducer 14 initially, and, once the first capacitor is charged, the second capacitor, which may be a much higher value capacitor, may then be coupled to the energy transducer 14. In addition, once the first capacitor is charged, the controller may automatically transmit a signal to the external transducer, thereby opening a communication channel with the external transducer, e.g., identifying the implant 10, identifying its optimal communication frequency, and the like.
For example, the first capacitor may charge in about fifty to two hundred milliseconds (50-200 ms), thereby allowing the implant to respond promptly upon detecting a signal from an external transducer, e.g., within about fifty to two hundred milliseconds (50-200 ms). The charge retained by the first capacitor, however, may only allow the implant 10 to transmit a short reply, e.g., an identification code or other one or two word acknowledgement, in response to an interrogation from the external transducer. The second capacitor may retain a more substantial charge, e.g., that may be used to operate the implant 10 for more extended periods of time, similar to the embodiment described above.
In a further alternative embodiment, the external transducer 70 and implant 10 may operate in a quasi-continuous state, i.e., alternating between energizing/charging modes and transmitting/receiving modes. For example, the external transducer 70 may transmit an energizing transmission, e.g., for between about one and one hundred milliseconds (1-100 msec.), to charge the energy storage device with sufficient energy to operate the implant 10 for a predetermined time, e.g., several milliseconds. The external transducer 70 may then switch to receiving mode, and the implant 10 may become activated, as described above, and sample and transmit data. After the predetermined time, the implant 10 may automatically switch back to charging mode and wait for another energizing transmission from the external transducer 70. After receiving the data transmission from the implant 10, the external transducer 70 may switch back to the energizing mode and transmit another energizing transmission to recharge the implant 10. Thus, the process of “interrogating,” i.e., requesting data from the implant 10, and transmitting sensor data may be repeated substantially indefinitely, as desired. For example, the external transducer 70 and implant 10 may operate at a predetermined duty cycle, e.g., at a rate of about fifteen to thirty Hertz (15-30 Hz), depending upon how much information is needed. This mode of operation may allow a smaller capacitor or other energy storage device to be used, while still allowing substantially continuous monitoring with no specific duration limit.
This quasi-continuous mode may also be implemented by the implant 10 in a hybrid mode. The external transducer 70 may transmit an energizing signal whenever the operation of the implant 10 allows it. For example, when the implant 10 is obtaining and/or processing data or between bits being transmitted by the implant 10, the energy transducer 14 may be available to receive additional energy from the external transducer. These additional energizing signals may be used to “top off” the charge on the energy storage device, thereby substantially extending the length of time that the implant 10 may operate.
In a further alternative embodiment (not shown), the implant may be operated in full-duplex mode. To facilitate this mode, the energy transducer is generally configured to transmit at a different frequency than the data signal transmissions of the implant. This may be achieved by providing one or more separate energy transmitters and receivers in the external transducer. Alternatively, the external transducer may include a single energy transducer and a circuit for separating the data transmission frequency, similar to the transmission circuit shown in
Although full-duplex mode allows continuous operation of the implant, the half-duplex mode also has advantages over the full-duplex mode. First, because of its higher efficiency, i.e., only activating components as they are needed, half-duplex mode may reduce the amount of energy consumed by the implant 10, allowing the implant 10 to operate at higher voltages, although for relatively short periods of time. Second, simultaneous energizing and transmitting in full-duplex mode may cause interference between the energizing and data signal transmissions. In particular, because the energizing transmission is much stronger than the data signal transmission, the energizing transmission may create background noise for the signal transmission. In half-duplex mode, the energizing and data signal transmissions are separated in time, increasing the fidelity and detection of the signal transmission. Finally, half-duplex mode may allow a single energy transducer to be used as both an energy exchanger and as a transmitter, simplifying construction of the implant and possibly reducing the amount of acoustic energy needed.
It will be appreciated that the above descriptions are intended only to serve as examples, and that many other embodiments are possible within the spirit and the scope of the present invention.
Wolinsky, Lone, Penner, Avi, Doron, Eyal, Ben-Yoseph, Alon
Patent | Priority | Assignee | Title |
10052097, | Jul 26 2012 | Nyxoah SA | Implant unit delivery tool |
10420479, | Apr 13 2011 | BRANCHPOINT & AURA DEVELOPMENT LLC | Sensor, circuitry, and method for wireless intracranial pressure monitoring |
10512782, | Jun 17 2013 | Nyxoah SA | Remote monitoring and updating of a medical device control unit |
10575731, | Oct 09 2013 | Senseonics, Incorporated | Use of a sensor with multiple external sensor transceiver devices |
10716560, | Jul 26 2012 | Nyxoah SA | Implant unit delivery tool |
10716940, | Oct 20 2009 | Nyxoah SA | Implant unit for modulation of small diameter nerves |
10751537, | Oct 20 2009 | Nyxoah SA | Arced implant unit for modulation of nerves |
10814137, | Jul 26 2012 | Nyxoah SA | Transcutaneous power conveyance device |
10918376, | Jul 26 2012 | Nyxoah SA | Therapy protocol activation triggered based on initial coupling |
11083386, | Apr 17 2014 | BRANCHPOINT & AURA DEVELOPMENT LLC | Wireless intracranial monitoring system |
11160506, | Mar 15 2013 | Microtech Medical Technologies Ltd | Implantable device with bridge |
11197622, | Apr 17 2014 | BRANCHPOINT & AURA DEVELOPMENT LLC | Wireless intracranial monitoring system |
11253712, | Jul 26 2012 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
11273307, | Oct 20 2009 | Nyxoah SA | Method and device for treating sleep apnea |
11298549, | Jun 17 2013 | Nyxoah SA | Control housing for disposable patch |
11426514, | Jun 03 2010 | Medtronic, Inc. | Implantable medical pump with pressure sensor |
11497399, | May 31 2016 | QURA, INC | Implantable intraocular pressure sensors and methods of use |
11564585, | Apr 13 2011 | BRANCHPOINT & AURA DEVELOPMENT LLC | Sensor, circuitry, and method for wireless intracranial pressure monitoring |
11642534, | Jun 17 2013 | Nyxoah SA | Programmable external control unit |
11730469, | Jul 26 2012 | Nyxoah SA | Implant unit delivery tool |
11857791, | Oct 20 2009 | Nyxoah SA | Arced implant unit for modulation of nerves |
8397578, | Jun 03 2010 | Medtronic, Inc | Capacitive pressure sensor assembly |
8594806, | Apr 30 2010 | LivaNova USA, Inc | Recharging and communication lead for an implantable device |
8649875, | Sep 10 2005 | Artann Laboratories Inc. | Systems for remote generation of electrical signal in tissue based on time-reversal acoustics |
8934972, | Oct 16 2000 | Remon Medical Technologies, Ltd. | Acoustically powered implantable stimulating device |
9024582, | Oct 27 2008 | Cardiac Pacemakers, Inc. | Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a body |
9643022, | Jun 17 2013 | Nyxoah SA | Flexible control housing for disposable patch |
9737657, | Jun 03 2010 | Medtronic, Inc | Implantable medical pump with pressure sensor |
9848789, | Apr 17 2014 | BRANCHPOINT & AURA DEVELOPMENT LLC | Wireless intracranial monitoring system |
9849289, | Oct 20 2009 | Nyxoah SA | Device and method for snoring detection and control |
9855032, | Jul 26 2012 | Nyxoah SA | Transcutaneous power conveyance device |
9901250, | Oct 09 2013 | Senseonics, Incorporated | Use of a sensor with multiple external sensor transceiver devices |
9901268, | Apr 13 2011 | BRANCHPOINT & AURA DEVELOPMENT LLC | Sensor, circuitry, and method for wireless intracranial pressure monitoring |
9901269, | Apr 17 2014 | BRANCHPOINT & AURA DEVELOPMENT LLC | Wireless intracranial monitoring system |
9943686, | Oct 20 2009 | Nyxoah SA | Method and device for treating sleep apnea based on tongue movement |
9950166, | Oct 20 2009 | Nyxoah SA | Acred implant unit for modulation of nerves |
Patent | Priority | Assignee | Title |
2786899, | |||
3536836, | |||
3672352, | |||
3757770, | |||
3805796, | |||
3853117, | |||
3943915, | Nov 29 1974 | Motorola, Inc. | Intracranial pressure sensing device |
3970987, | Feb 10 1972 | Signal Science, Inc. | Acoustical switch |
4026276, | Apr 05 1976 | The Johns Hopkins University | Intracranial pressure monitor |
4041954, | May 07 1974 | Kabushiki Kaisha Daini Seikosha | System for detecting information in an artificial cardiac pacemaker |
4062354, | Jul 01 1975 | Intracranial pressure transducer system | |
4082097, | May 20 1976 | Pacesetter AB | Multimode recharging system for living tissue stimulators |
4099530, | Apr 27 1977 | American Pacemaker Corporation | Cardiac pacer circuitry to facilitate testing of patient heart activity and pacer pulses |
4127110, | May 24 1976 | Huntington Institute of Applied Medical Research | Implantable pressure transducer |
4170742, | Jul 15 1974 | Pioneer Electronic Corporation; Tokorozawa Electronic Corporation | Piezoelectric transducer with multiple electrode areas |
4206761, | Jun 21 1976 | RADIONICS, INC | Pressure-balanced telemetric pressure sensing method |
4206762, | Jun 21 1976 | RADIONICS, INC | Telemetric differential pressure sensing method |
4265252, | Apr 19 1978 | The Johns Hopkins University | Intracranial pressure implant |
4281666, | Jun 21 1976 | Single diaphragm pressure-balanced telemetric pressure sensing system | |
4281667, | Jun 21 1976 | INTEGRA LIFESCIENCES CORPORATION | Single diaphragm telemetric differential pressure sensing system |
4340038, | Dec 15 1980 | Pacesetter AB | Magnetic field concentration means and method for an implanted device |
4354506, | Jan 17 1980 | Naganokeiki Seisakujo Company, Ltd. | Intracranial pressure gauge |
4361153, | May 27 1980 | Pacesetter, Inc | Implant telemetry system |
4378809, | Apr 13 1978 | RADIONICS, INC | Audio-telemetric pressure sensing systems and methods |
4385636, | Apr 13 1978 | INTEGRA LIFESCIENCES CORPORATION | Telemetric differential pressure sensor with the improvement of a conductive shorted loop tuning element and a resonant circuit |
4407296, | Sep 12 1980 | Medtronic, Inc. | Integral hermetic impantable pressure transducer |
4471786, | Apr 27 1981 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Telemetering intracranial pressure transducer |
4481950, | Apr 27 1979 | Medtronic, Inc. | Acoustic signalling apparatus for implantable devices |
4494950, | Jan 19 1982 | The Johns Hopkins University | Plural module medication delivery system |
4519401, | Sep 20 1983 | Case Western Reserve University | Pressure telemetry implant |
4556061, | Aug 18 1982 | Pacesetter, Inc | Cardiac pacer with battery consumption monitor circuit |
4593703, | Jun 21 1976 | INTEGRA LIFESCIENCES CORPORATION | Telemetric differential pressure sensor with the improvement of a conductive shorted loop tuning element and a resonant circuit |
4596255, | Nov 08 1982 | PACESETTER, INC , A ST JUDE MEDICAL COMPANY | Apparatus for interpreting and displaying cardiac events of a heart connected to a cardiac pacing means |
4614192, | Apr 21 1982 | MIROWSKI FAMILY VENTURES L L C | Implantable cardiac defibrillator employing bipolar sensing and telemetry means |
4616640, | Nov 14 1983 | CORNELL RESEARCH FOUNDATION, INC , A CORP OF N Y | Birth control method and device employing electric forces |
4651740, | Feb 19 1985 | Pacesetter, Inc | Implant and control apparatus and method employing at least one tuning fork |
4653508, | Jun 21 1976 | INTEGRA LIFESCIENCES CORPORATION | Pressure-balanced telemetric pressure sensing system and method therefore |
4660568, | Jun 21 1976 | INTEGRA LIFESCIENCES CORPORATION | Telemetric differential pressure sensing system and method therefore |
4676255, | Jul 03 1985 | INTEGRA LIFESCIENCES CORPORATION | Telemetric in-vivo calibration method and apparatus using a negative pressure applicator |
4677985, | Aug 12 1985 | BARROW NEUROLOGICAL INSTITUTE; WILLIAM J BRO; PHILIP L CARTER | Apparatus and method for determining intracranial pressure and local cerebral blood flow |
4708127, | Oct 24 1985 | WELLS FARGO BANK, NATIONAL ASSOCIATION FLAIR INDUSTRIAL PARK RCBO | Ultrasonic generating system with feedback control |
4719919, | Jan 21 1983 | COOK INCORPORATED A CORPORATION OF IN | Implantable hyperthermia device and system |
4791915, | Sep 29 1986 | Dynawave Corporation | Ultrasound therapy device |
4791936, | Nov 08 1982 | Pacesetter AB | Apparatus for interpreting and displaying cardiac events of a heart connected to a cardiac pacing means |
4793825, | Sep 11 1984 | The Secretary of State for Defence in Her Britannic Majesty's Government | Active silicon implant devices |
4869251, | Jul 15 1986 | Pacesetter AB | Implantable heart pacemaker with a sensor for inertial and/or rotational movements of the user |
4885002, | Nov 04 1986 | KABUSHIKI KAISHA NIHON M D M , NICHINAN-BOEKI BLDG , A JAPANESE COMPANY | Brain ventricle shunt system |
4911217, | Mar 24 1989 | The Goodyear Tire & Rubber Company; GOODYEAR TIRE & RUBBER COMPANY, THE | Integrated circuit transponder in a pneumatic tire for tire identification |
4918736, | Sep 27 1984 | BELTONE NETHERLANDS B V | Remote control system for hearing aids |
5074310, | Jul 31 1990 | MEDYS, INC | Method and apparatus for the measurement of intracranial pressure |
5113859, | Sep 19 1988 | Medtronic, Inc. | Acoustic body bus medical device communication system |
5117835, | Jul 30 1991 | MEDYS, INC | Method and apparatus for the measurement of intracranial pressure |
5160870, | Jun 25 1990 | CARSON, PAUL L ; ROBINSON, ANDREW L ; FITTING, DALE W ; TERRY, FRED L | Ultrasonic image sensing array and method |
5168869, | Jun 17 1991 | Rate responsive pacemaker controlled by isovolumic contraction time | |
5184605, | Jan 31 1991 | Excel Tech Ltd. | Therapeutic ultrasound generator with radiation dose control |
5218861, | Mar 27 1991 | GOODYEAR TIRE & RUBBER COMPANY, THE | Pneumatic tire having an integrated circuit transponder and pressure transducer |
5279292, | Feb 13 1991 | Cochlear Limited | Charging system for implantable hearing aids and tinnitus maskers |
5291899, | May 10 1990 | Kabushiki Kaisha Nihon M.D.M. | Method and device for measuring intracranial pressure |
5381067, | Mar 10 1993 | Hewlett-Packard Company | Electrical impedance normalization for an ultrasonic transducer array |
5423334, | Feb 01 1993 | C R BARD, INC | Implantable medical device characterization system |
5433736, | Jan 29 1993 | Pacesetter AB | Implantable medical apparatus and extracorporeal programming and control unit therefor |
5445150, | Nov 18 1991 | General Electric Company | Invasive system employing a radiofrequency tracking system |
5495453, | Oct 19 1994 | U S BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT | Low power voltage detector circuit including a flash memory cell |
5562621, | Nov 22 1993 | Advanced Cardiovascular Systems, INC | Communication system for linking a medical device with a remote console |
5619997, | Jan 28 1994 | MIZUR TECHNOLOGY LTD | Passive sensor system using ultrasonic energy |
5620475, | Apr 25 1994 | Siemens Elema AB | Extracorporeally controllable medical implant and method for operating same |
5704352, | Nov 22 1995 | Remon Medical Technologies LTD | Implantable passive bio-sensor |
5704366, | May 23 1994 | Nortek Security & Control LLC | System for monitoring and reporting medical measurements |
5712917, | Nov 22 1994 | George C., Offutt | System and method for creating auditory sensations |
5721886, | Nov 30 1995 | NCR Corporation | Synchronizer circuit which controls switching of clocks based upon synchronicity, asynchronicity, or change in frequency |
5724985, | Aug 02 1995 | Pacesetter, Inc.; Pacesetter, Inc | User interface for an implantable medical device using an integrated digitizer display screen |
5743267, | Oct 19 1995 | Telecom Medical, Inc. | System and method to monitor the heart of a patient |
5749909, | Nov 07 1996 | Sulzer Intermedics Inc. | Transcutaneous energy coupling using piezoelectric device |
5757104, | Oct 10 1994 | Endress + Hauser GmbH + Co. | Method of operating an ultransonic piezoelectric transducer and circuit arrangement for performing the method |
5759199, | Aug 02 1995 | Pacesetter, Inc.; Pacesetter, Inc | System and method for ambulatory monitoring and programming of an implantable medical device |
5800478, | Mar 07 1996 | PURDUE PHARMACEUTICAL PRODUCTS L P | Flexible microcircuits for internal light therapy |
5807258, | Oct 14 1997 | Pacesetter, Inc | Ultrasonic sensors for monitoring the condition of a vascular graft |
5814089, | Dec 18 1996 | JARO, MICHAEL J | Leadless multisite implantable stimulus and diagnostic system |
5833603, | Mar 13 1996 | Allergan, Inc | Implantable biosensing transponder |
5861018, | May 28 1996 | Telecom Medical Inc. | Ultrasound transdermal communication system and method |
5891180, | Apr 29 1998 | Medtronic Inc. | Interrogation of an implantable medical device using audible sound communication |
5904708, | Mar 19 1998 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
5925001, | Apr 11 1994 | Foot contact sensor system | |
5935078, | Jan 30 1996 | Telecom Medical, Inc. | Transdermal communication system and method |
5957861, | Jan 31 1997 | Medtronic, Inc.; Medtronic, Inc | Impedance monitor for discerning edema through evaluation of respiratory rate |
5967989, | Oct 14 1997 | Pacesetter, Inc | Ultrasonic sensors for monitoring the condition of a vascular graft |
6015387, | Mar 20 1997 | TRICARDIA, L L C | Implantation devices for monitoring and regulating blood flow |
6030374, | Apr 03 1998 | L OREAL S A | Ultrasound enhancement of percutaneous drug absorption |
6070103, | Nov 05 1996 | Intermedics Inc. | Apparatus for making direct electrical connection with an implantable medical device |
6140740, | Dec 30 1997 | Remon Medical Technologies, Ltd | Piezoelectric transducer |
6141588, | Jul 24 1998 | Intermedics Inc | Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy |
6162238, | Feb 24 1999 | KAPLAN, AARON V | Apparatus and methods for control of body lumens |
6164284, | Feb 26 1997 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | System of implantable devices for monitoring and/or affecting body parameters |
6167303, | Apr 29 1998 | Medtronic, Inc.; Medtronic, Inc | Power consumption reduction in medical devices employing just-in-time clock |
6170488, | Mar 24 1999 | PMD HOLDINGS CORPORATION, A CORPORATION OF ILLINOIS | Acoustic-based remotely interrogated diagnostic implant device and system |
6176840, | Aug 11 1997 | PANASONIC ELECTRIC WORKS CO , LTD | Ultrasonic cosmetic treatment device |
6183426, | May 15 1997 | PANASONIC ELECTRIC WORKS CO , LTD | Ultrasonic wave applying apparatus |
6185452, | Feb 26 1997 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Battery-powered patient implantable device |
6185454, | Apr 29 1998 | Medtronic, Inc.; Medtronic, Inc | Power consumption reduction in medical devices employing just-in-time voltage control |
6185460, | Apr 29 1998 | Medtronic, Inc. | Power consumption reduction in medical devices employing multiple digital signal processors |
6198963, | Jul 17 1996 | Biosense, Inc | Position confirmation with learn and test functions |
6198965, | Dec 30 1997 | Remon Medical Technologies, Ltd | Acoustic telemetry system and method for monitoring a rejection reaction of a transplanted organ |
6198971, | Apr 08 1999 | Cochlear Limited | Implantable system for rehabilitation of a hearing disorder |
6200265, | Apr 16 1999 | Medtronic, Inc.; Medtronic, Inc | Peripheral memory patch and access method for use with an implantable medical device |
6236889, | Jan 22 1999 | Medtronic, Inc.; Medtronic, Inc | Method and apparatus for accoustically coupling implantable medical device telemetry data to a telephonic connection |
6237398, | Dec 30 1997 | Remon Medical Technologies, Ltd | System and method for monitoring pressure, flow and constriction parameters of plumbing and blood vessels |
6248080, | Oct 30 1998 | Medtronic, Inc | Intracranial monitoring and therapy delivery control device, system and method |
6259951, | May 14 1999 | Advanced Bionics AG | Implantable cochlear stimulator system incorporating combination electrode/transducer |
6260152, | Jul 30 1998 | UNIFY, INC | Method and apparatus for synchronizing data transfers in a logic circuit having plural clock domains |
6261249, | Mar 17 1998 | Exogen Inc. | Ultrasonic treatment controller including gel sensing circuit |
6277078, | Nov 19 1999 | Remon Medical Technologies, Ltd | System and method for monitoring a parameter associated with the performance of a heart |
6315721, | Feb 26 1997 | Boston Scientific Neuromodulation Corporation | System of implantable devices for monitoring and/or affecting body parameters |
6431175, | Dec 30 1997 | Remon Medical Technologies, Ltd | System and method for directing and monitoring radiation |
6432050, | Dec 30 1997 | Remon Medical Technologies, Ltd | Implantable acoustic bio-sensing system and method |
6442413, | May 15 2000 | Implantable sensor | |
6442433, | Oct 26 1999 | Medtronic, Inc.; Medtronic, Inc | Apparatus and method for remote troubleshooting, maintenance and upgrade of implantable device systems |
6472991, | Jun 15 2001 | Alfred E. Mann Foundation for Scientific Research | Multichannel communication protocol configured to extend the battery life of an implantable device |
6473638, | Dec 24 1999 | Medtronic, Inc | Medical device GUI for cardiac electrophysiology display and data communication |
6564807, | Feb 26 1997 | Alfred E. Mann Foundation for Scientific Research | System of implantable devices for monitoring and/or affecting body parameters |
6577899, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6584352, | Dec 27 2000 | Medtronic INC | Leadless fully automatic pacemaker follow-up |
6607485, | Jun 03 1999 | Cardiac Intelligence Corporation | Computer readable storage medium containing code for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
6628989, | Oct 16 2000 | Remon Medical Technologies, Ltd. | Acoustic switch and apparatus and methods for using acoustic switches within a body |
6644322, | Jun 23 2000 | Medtronic, Inc | Human language translation of patient session information from implantable medical devices |
6664763, | Apr 26 1999 | Exonix Corporation | System for managing power to an implanted device based on operating time, current drain and battery capacity |
6671552, | Oct 02 2001 | Medtronic, Inc | System and method for determining remaining battery life for an implantable medical device |
6676601, | May 26 1999 | Technomed Medical Systems, S.A.; Institut National de la Sante et de la Recherche Medicale (INSERM) | Apparatus and method for location and treatment using ultrasound |
6689091, | Aug 02 1996 | BAXTER INTERNATIONAL, INC | Medical apparatus with remote control |
6712772, | Nov 29 2001 | ASTORA WOMEN S HEALTH, LLC | Low power consumption implantable pressure sensor |
6731976, | Oct 30 1998 | Medtronic, Inc | Device and method to measure and communicate body parameters |
6735532, | Sep 30 1998 | L. Vad Technology, Inc. | Cardiovascular support control system |
6754538, | Oct 29 1999 | Medtronic, Inc. | Apparatus and method for remote self-identification of components in medical device systems |
6764446, | Oct 16 2000 | Remon Medical Technologies LTD | Implantable pressure sensors and methods for making and using them |
6790187, | Aug 24 2000 | TIMI 3 SYSTEMS, INC | Systems and methods for applying ultrasonic energy |
6799280, | Jan 04 2000 | Advanced Micro Devices, INC | System and method for synchronizing data transfer from one domain to another by selecting output data from either a first or second storage device |
6804557, | Oct 11 2001 | Pacesetter, Inc | Battery monitoring system for an implantable medical device |
6826430, | Mar 31 2000 | Advanced Bionics AG | High contact count, sub-miniature, fully implantable cochlear prosthesis |
6855115, | Jan 22 2002 | ST JUDE MEDICAL LUXEMBOURG HOLDINGS II S A R L SJM LUX II | Implantable wireless sensor for pressure measurement within the heart |
6873869, | May 07 1999 | Schiller Medical | Method and apparatus for obtaining an electrocardiograph |
6960801, | Jun 14 2001 | Macronix International Co., Ltd. | High density single transistor ferroelectric non-volatile memory |
6970037, | Sep 05 2003 | DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT | Programmable analog bias circuits using floating gate CMOS technology |
6978181, | May 24 2002 | Pacesetter, Inc. | Inter-programmer communication among programmers of implantable medical devices |
6985088, | Mar 15 2002 | Medtronic, Inc | Telemetry module with configurable data layer for use with an implantable medical device |
6985773, | Feb 07 2002 | Cardiac Pacemakers, Inc | Methods and apparatuses for implantable medical device telemetry power management |
6988215, | Sep 14 2001 | Medtronic, Inc | Method and apparatus for synchronization of clock domains |
6993393, | Dec 19 2001 | Cardiac Pacemakers, Inc | Telemetry duty cycle management system for an implantable medical device |
7003349, | Dec 16 1999 | ST JUDE MEDICAL AB | Programming system for medical devices |
7013178, | Sep 25 2002 | Medtronic, Inc | Implantable medical device communication system |
7024248, | Oct 16 2000 | Remon Medical Technologies LTD | Systems and methods for communicating with implantable devices |
7027871, | Oct 31 2002 | Medtronic, Inc | Aggregation of data from external data sources within an implantable medical device |
7027872, | Mar 31 2000 | Medtronic, Inc. | Variable encryption scheme for data transfer between medical devices and related data management systems |
7035684, | Feb 26 2003 | Medtronic, Inc. | Method and apparatus for monitoring heart function in a subcutaneously implanted device |
7060030, | Jan 08 2002 | Cardiac Pacemakers, Inc | Two-hop telemetry interface for medical device |
7061381, | Apr 05 2002 | BeezerBug Incorporated | Ultrasonic transmitter and receiver systems and products using the same |
7082334, | Dec 19 2001 | Medtronic, Inc | System and method for transmission of medical and like data from a patient to a dedicated internet website |
7096068, | Jan 17 2002 | Cardiac Pacemakers, Inc | User-attachable or detachable telemetry module for medical devices |
7123964, | Feb 15 2003 | Medtronic, Inc. | Replacement indicator timer for implantable medical devices |
7198603, | Apr 14 2003 | Remon Medical Technologies LTD | Apparatus and methods using acoustic telemetry for intrabody communications |
7203551, | Apr 25 2003 | Medtronic, Inc | Implantable lead-based sensor powered by piezoelectric transformer |
7209790, | Sep 30 2002 | Medtronic, Inc | Multi-mode programmer for medical device communication |
7212133, | Mar 15 2002 | Medtronic, Inc. | Telemetry module with configurable data layer for use with an implantable medical device |
7236821, | Feb 19 2002 | Cardiac Pacemakers, Inc | Chronically-implanted device for sensing and therapy |
7273457, | Oct 16 2000 | Remon Medical Technologies, Ltd | Barometric pressure correction based on remote sources of information |
7283874, | Oct 16 2000 | Remon Medical Technologies LTD | Acoustically powered implantable stimulating device |
7286872, | Oct 07 2003 | Cardiac Pacemakers, Inc | Method and apparatus for managing data from multiple sensing channels |
7319903, | Apr 07 2004 | Cardiac Pacemakers, Inc | System and method for RF transceiver duty cycling in an implantable medical device |
7335161, | Aug 20 2004 | Cardiac Pacemakers, Inc | Techniques for blood pressure measurement by implantable device |
7353063, | Dec 22 2004 | Cardiac Pacemakers, Inc | Generating and communicating web content from within an implantable medical device |
7469161, | Dec 16 2004 | Cardiac Pacemakers, Inc. | Systems and methods for monitoring and managing power consumption of an implantable medical device |
7479108, | Jan 29 2002 | VTQ IP HOLDING CORPORATION | Methods for using an implantable sensor unit |
20010025139, | |||
20020045921, | |||
20020065540, | |||
20020077673, | |||
20020151770, | |||
20030114897, | |||
20030212441, | |||
20040039424, | |||
20040133092, | |||
20040152999, | |||
20040172083, | |||
20040210141, | |||
20050113705, | |||
20050159785, | |||
20050159789, | |||
20050288727, | |||
20060009818, | |||
20060020307, | |||
20060025834, | |||
20060031378, | |||
20060041287, | |||
20060041288, | |||
20060058627, | |||
20060064134, | |||
20060064135, | |||
20060064142, | |||
20060085039, | |||
20060122667, | |||
20060142819, | |||
20060149329, | |||
20070010742, | |||
20070142728, | |||
20070150014, | |||
20070162090, | |||
20070179549, | |||
20070250126, | |||
20080015421, | |||
20080071178, | |||
20080103553, | |||
20080108915, | |||
20080171941, | |||
20080195002, | |||
20080243210, | |||
20090312650, | |||
20090326609, | |||
20100023091, | |||
20100106028, | |||
EP499939, | |||
EP928598, | |||
EP1962557, | |||
WO232502, | |||
WO3043688, | |||
WO2007080487, | |||
WO47109, | |||
WO1028627, | |||
WO1074278, | |||
WO1097907, | |||
WO128627, | |||
WO174274, | |||
WO174278, | |||
WO2003347, | |||
WO203347, | |||
WO3002243, | |||
WO3096889, | |||
WO2005009535, | |||
WO2005053786, | |||
WO2006060668, | |||
WO2007070794, | |||
WO2007127696, | |||
WO2008118908, | |||
WO8802250, | |||
WO98043338, | |||
WO9843338, | |||
WO99034453, | |||
WO9934453, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jun 10 2001 | WOLINSKY, LONE | Remon Medical Technologies, Ltd | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020548 | /0711 | |
Jun 10 2001 | DORON, EYAL | Remon Medical Technologies, Ltd | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020548 | /0711 | |
Jun 10 2001 | BEN-YOSEFH, ALON | Remon Medical Technologies, Ltd | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020548 | /0711 | |
Jun 10 2001 | PENNER, AVI | Remon Medical Technologies, Ltd | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020548 | /0711 | |
Jul 20 2006 | Remon Medical Technologies, Ltd. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Mar 03 2011 | ASPN: Payor Number Assigned. |
Dec 21 2011 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Jan 06 2016 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
May 17 2014 | 4 years fee payment window open |
Nov 17 2014 | 6 months grace period start (w surcharge) |
May 17 2015 | patent expiry (for year 4) |
May 17 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
May 17 2018 | 8 years fee payment window open |
Nov 17 2018 | 6 months grace period start (w surcharge) |
May 17 2019 | patent expiry (for year 8) |
May 17 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
May 17 2022 | 12 years fee payment window open |
Nov 17 2022 | 6 months grace period start (w surcharge) |
May 17 2023 | patent expiry (for year 12) |
May 17 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |